Literature DB >> 31787480

Prevalence and outcomes of young people with concurrent autism spectrum disorder and first episode of psychosis.

Monica Sunwoo1, Jessica O'Connell2, Ellie Brown3, Ashleigh Lin4, Stephen J Wood5, Patrick McGorry3, Brian O'Donoghue6.   

Abstract

BACKGROUND: The intersect and blurring of boundaries between schizophrenia spectrum disorders and autism spectrum disorder (ASD) has long been an area of confusion, in both nosology and clinical practice. Individuals with a comorbid presentation of the two spectra can present with a distinct phenomenological profile to those with psychosis or ASD alone. AIMS: To examine the prevalence rates of ASD in a cohort of young people presenting with a first episode of psychosis (FEP) and compare the demographic and clinical characteristics and functional outcomes between individuals with concurrent FEP and ASD, and individuals with FEP only.
METHODS: Young people aged 15 to 24 who presented with FEP to the Early Psychosis Prevention and Intervention Centre (EPPIC) between 1st January 2011 and 31st December 2013 were included in the study.
RESULTS: Of the 544 individuals presenting with a FEP, 3.7% (N = 20) had a diagnosis of ASD. Individuals with a concurrent diagnosis of FEP and ASD were more likely to be male and less likely to have comorbid substance use issues. There was no difference found in the severity of psychotic symptoms or diagnoses between groups. Those with FEP and ASD were more likely to experience impairments in interpersonal skills and be more likely to be engaged in employment or education at time of discharge from service.
CONCLUSIONS: Individuals with concurrent FEP and ASD can present with distinct clinical characteristics that require specialised assessment and treatment. Further large-scale studies with control groups could help to better understand the phenomenological specificity of this subgroup.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autism spectrum disorder; Early intervention; Outcomes; Psychosis; Schizophrenia

Mesh:

Year:  2019        PMID: 31787480     DOI: 10.1016/j.schres.2019.11.037

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  4 in total

Review 1.  Autism spectrum disorder and schizophrenia: An updated conceptual review.

Authors:  Amandeep Jutla; Jennifer Foss-Feig; Jeremy Veenstra-VanderWeele
Journal:  Autism Res       Date:  2021-12-29       Impact factor: 5.216

2.  Categorical and Dimensional Approaches to Examining the Joint Effect of Autism and Schizotypal Personality Disorder on Sustained Attention.

Authors:  Ahmad Abu-Akel; Ruth C M Philip; Stephen M Lawrie; Eve C Johnstone; Andrew C Stanfield
Journal:  Front Psychiatry       Date:  2020-08-07       Impact factor: 4.157

3.  Cannabis and cannabidiol use among autistic and non-autistic adults in the UK: a propensity score-matched analysis.

Authors:  Daniel Ying-Heng Hua; Rachel Lees; Mark Brosnan; Tom P Freeman
Journal:  BMJ Open       Date:  2021-12-16       Impact factor: 2.692

4.  Understanding the impact of SNPs associated with autism spectrum disorder on biological pathways in the human fetal and adult cortex.

Authors:  E Golovina; T Fadason; T J Lints; C Walker; M H Vickers; J M O'Sullivan
Journal:  Sci Rep       Date:  2021-08-05       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.